BNP Paribas Financial Markets
CPXX

BNP Paribas Financial Markets’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BNP Paribas Financial Markets’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,292
Closed -$39K – 3613
2016
Q2 		$39K Buy
+1,292
New +$26.2K ﹤0.01% 2371

BNP Paribas Financial Markets's CPXX Position: Q3 2016 in Review

BNP Paribas Financial Markets sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 1,292 shares — an estimated $39K sold.

BNP Paribas Financial Markets first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $39K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • BNP Paribas Financial Markets reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,292 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $39K.
  • BNP Paribas Financial Markets first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • BNP Paribas Financial Markets's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $39K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2016, filed 5 Oct 2016.